- Tytuł:
- A phase I, open-label, two-stage study to investigate the safety, tolerability, pharmacokinetics, and pharmacodynamics of the oral AKT inhibitor GSK2141795 in patients with solid tumors
- Autorzy:
- Źródło:
- Investigational New Drugs: Novel Anti-Cancer Therapeutics and Therapies. 36(6):1016-1025
Czasopismo naukowe